Director/PDMR Shareholding

5 Dec 2006 18:18

ReGen Therapeutics PLC05 December 2006 DIRECTOR SHAREHOLDING London, UK - 5 December, 2006: ReGen Therapeutics Plc (the "Company") announcesthat it has today received notification from Dr P. Garrod, a non-executivedirector, that he has acquired 500,000 ordinary shares of the Company at 1.15pper share. Dr Garrod now holds and is beneficially interested in 66,750,000ordinary shares representing 9.61% of the current issued share capital of theCompany. For further information, please contact: Andrew Marshall Tel. 020 7960 6007Greycoat Communications This information is provided by RNS The company news service from the London Stock Exchange